Xeris Other Assets from 2010 to 2025

XERS Stock  USD 4.82  0.26  5.70%   
Xeris Pharmaceuticals Other Assets yearly trend continues to be comparatively stable with very little volatility. Other Assets are likely to outpace its year average in 2025. From the period from 2010 to 2025, Xeris Pharmaceuticals Other Assets quarterly data regression had r-value of  0.80 and coefficient of variation of  158.63. View All Fundamentals
 
Other Assets  
First Reported
2016-12-31
Previous Quarter
4.8 M
Current Value
1
Quarterly Volatility
1.6 M
 
Covid
Check Xeris Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xeris Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 5.6 M, Depreciation And Amortization of 13.3 M or Interest Expense of 32 M, as well as many indicators such as Price To Sales Ratio of 2.33, Dividend Yield of 0.0 or Days Sales Outstanding of 69.01. Xeris financial statements analysis is a perfect complement when working with Xeris Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Xeris Pharmaceuticals Correlation against competitors.
For more information on how to buy Xeris Stock please use our How to Invest in Xeris Pharmaceuticals guide.

Latest Xeris Pharmaceuticals' Other Assets Growth Pattern

Below is the plot of the Other Assets of Xeris Pharmaceuticals over the last few years. It is Xeris Pharmaceuticals' Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xeris Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Slightly volatile
   Other Assets   
       Timeline  

Xeris Other Assets Regression Statistics

Arithmetic Mean1,417,061
Geometric Mean259,553
Coefficient Of Variation158.63
Mean Deviation1,867,841
Median157,000
Standard Deviation2,247,851
Sample Variance5.1T
Range5.7M
R-Value0.80
Mean Square Error2T
R-Squared0.64
Significance0.0002
Slope376,744
Total Sum of Squares75.8T

Xeris Other Assets History

20255.7 M
20245.4 M
20224.7 M
2021829 K
2020232 K
2019420 K
201895 K

About Xeris Pharmaceuticals Financial Statements

Xeris Pharmaceuticals shareholders use historical fundamental indicators, such as Other Assets, to determine how well the company is positioned to perform in the future. Although Xeris Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Xeris Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Xeris Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Assets5.4 M5.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xeris Stock Analysis

When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.